Clinical Trials Logo

Clinical Trial Summary

Probiotics have become very popular and are by WHO defined as "Live microorganisms which when administered in adequate amounts confer a health benefit on the host". For example, probiotics have been shown to contribute to improvements of abdominal discomfort and intestinal inflammation. The main hypothesis behind the present study is that probiotics influences mucosal regulatory systems, particularly the actions of the hormone Angiotensin II locally in the intestinal mucosa.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • the Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in Man

NCT number NCT01635192
Study type Interventional
Source Göteborg University
Contact
Status Completed
Phase Early Phase 1
Start date December 2011
Completion date July 2013